ES452923A1 - Procedimiento para la preparacion de un agente antihemofili-co. - Google Patents

Procedimiento para la preparacion de un agente antihemofili-co.

Info

Publication number
ES452923A1
ES452923A1 ES452923A ES452923A ES452923A1 ES 452923 A1 ES452923 A1 ES 452923A1 ES 452923 A ES452923 A ES 452923A ES 452923 A ES452923 A ES 452923A ES 452923 A1 ES452923 A1 ES 452923A1
Authority
ES
Spain
Prior art keywords
manufacture
antihemophilic
agent
antihemophilic agent
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES452923A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of ES452923A1 publication Critical patent/ES452923A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/851—Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ES452923A 1975-11-07 1976-11-02 Procedimiento para la preparacion de un agente antihemofili-co. Expired ES452923A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550011A DE2550011C2 (de) 1975-11-07 1975-11-07 Verfahren zur Herstellung eines antihämophilen Mittels

Publications (1)

Publication Number Publication Date
ES452923A1 true ES452923A1 (es) 1977-11-16

Family

ID=5961172

Family Applications (1)

Application Number Title Priority Date Filing Date
ES452923A Expired ES452923A1 (es) 1975-11-07 1976-11-02 Procedimiento para la preparacion de un agente antihemofili-co.

Country Status (20)

Country Link
US (1) US4067964A (es)
JP (1) JPS6029362B2 (es)
AT (1) AT358737B (es)
AU (1) AU500621B2 (es)
BE (1) BE848111A (es)
CA (1) CA1077393A (es)
CH (1) CH630805A5 (es)
DE (1) DE2550011C2 (es)
DK (1) DK502176A (es)
ES (1) ES452923A1 (es)
FI (1) FI763165A (es)
FR (1) FR2330408A1 (es)
GB (1) GB1563009A (es)
IL (1) IL50847A (es)
IT (1) IT1063617B (es)
LU (1) LU76145A1 (es)
NL (1) NL7612139A (es)
NO (1) NO763776L (es)
SE (1) SE7612396L (es)
ZA (1) ZA766647B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0044343B1 (en) * 1980-01-28 1984-08-22 Baxter Travenol Laboratories, Inc. Prothrombin-containing therapeutic compositions and methods of producing enzymatically active blood clotting factors from prothrombin-containing blood fractions
US4459288A (en) * 1981-05-11 1984-07-10 Baxter Travenol Laboratories, Inc. Therapeutic blood clotting factor compositions and their use
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
JP2931319B2 (ja) * 1989-03-29 1999-08-09 吉富製薬株式会社 血液凝固第▲ｖｉｉｉ▼因子の製造法
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
AU2002229510A1 (en) * 2001-02-05 2002-08-19 Novo Nordisk Health Care Ag Combined use of factor vii polypeptides and factor viii polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862002A (en) * 1962-05-08 1975-01-21 Sanfar Lab Inc Production of physiologically active placental substances
BE713764A (es) * 1967-05-01 1968-09-16 Baxter Travenol Lab
BE787961A (fr) * 1971-08-24 1973-02-26 Behringwerke Ag Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma

Also Published As

Publication number Publication date
DE2550011C2 (de) 1982-11-25
DK502176A (da) 1977-05-08
LU76145A1 (es) 1977-06-03
JPS5257310A (en) 1977-05-11
CH630805A5 (de) 1982-07-15
FR2330408A1 (fr) 1977-06-03
NL7612139A (nl) 1977-05-10
NO763776L (es) 1977-05-10
ATA819476A (de) 1980-02-15
BE848111A (fr) 1977-05-09
JPS6029362B2 (ja) 1985-07-10
SE7612396L (sv) 1977-05-08
IL50847A (en) 1980-01-31
FI763165A (es) 1977-05-08
AT358737B (de) 1980-09-25
US4067964A (en) 1978-01-10
AU1934176A (en) 1978-05-11
DE2550011A1 (de) 1977-05-12
FR2330408B1 (es) 1980-03-14
ZA766647B (en) 1977-10-26
IL50847A0 (en) 1977-01-31
AU500621B2 (en) 1979-05-24
IT1063617B (it) 1985-02-11
GB1563009A (en) 1980-03-19
CA1077393A (en) 1980-05-13

Similar Documents

Publication Publication Date Title
NL7803460A (nl) Werkwijze ter vervaardiging van naaldvormige, ferromagnetische ijzerdeeltjes.
ES477783A1 (es) Un procedimiento de preparacion de benzamidas heterocicli- cas sustituidas.
NL7710520A (nl) Werkwijze voor de elektrolytische bereiding van joodwaterstof.
ES452923A1 (es) Procedimiento para la preparacion de un agente antihemofili-co.
NL7612649A (nl) Werkwijze ter vervaardiging van suppositoria, alsmede aldus vervaardigde suppositoria.
NL167196B (nl) Werkwijze ter bereiding van wasmiddelen, alsmede daar- uit verkregen gevormde wasmiddelen.
IT1113523B (it) Lega sinterizzata,molto resistente,ferro-molibdeno-nichel con aggiunta di fosforo
BG32856A3 (bg) Метод за получаване на 1-оксадетилацефалоспорий
NL7806262A (nl) Samengesteld drukgevoelig voorwerp, werkwijze ter ver- vaardiging daarvan, alsmede substraat/voorwerpcombina- tie.
SE382645B (sv) Hardmetallartikel, bestaende av karbid och bindemetall av koboltlegering och sett att framstella denna.
JPS5234859A (en) Process for forming beard introduction holes for an outer blade of an electric shaver
JPS5211525A (en) Method of manufacturing headrests
JPS52130993A (en) Production of pullane in the presence of amylase inhibitor
BG28062A3 (en) Method of obtaining of 6a,10a, cishexahydrodibenzopyranones
JPS535587A (en) Piezoelectric oscillator
JPS5223581A (en) Antifreeze composition and production process for same
JPS5233633A (en) Process for preparation of p-phenylenediamine
SU554223A1 (ru) Эмаль
NL7703083A (nl) Werkwijze voor de vervaardiging van ferriet- magneetkernen, alsmede magneetkernen vervaar- digd volgens deze werkwijze.
JPS51117103A (en) Alloy wire material for addition of rare earth
USD178707S (en) Religious candle holder
SU645220A1 (ru) Держатель электронных ламп
USD168565S (en) Earring or the like
IT7924308A0 (it) Lega dura particolarmente per utensileria e procedimento per produrla.
BG35595A3 (en) Method for preparing quinoxaline -1, 4- dioxides

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103